In line with CTCs from non-small cell lung cancer [38], urothelial carcinoma [39] or prostate cancer [40], CTCs from patients with vulvar or cervical cancer exhibited pre-therapeutic PD-L1 expression. This evidence concerns the gene CD274 and prostate carcinoma.